Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 4242  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
Read this article


    Article Cited by others


Current trends in the pharmacotherapy of diabetic retinopathy

Kumar B, Gupta S K, Saxena R, Srivastava S

Year : 2012| Volume: 58| Issue : 2 | Page no: 132-139

   This article has been cited by
1 Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches
Murugan Prasathkumar, Robert Becky, Salim Anisha, Chenthamara Dhrisya, Subramaniam Sadhasivam
Biotechnology Letters. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Redoxisome and Diabetic Retinopathy: Pathophysiology and Therapeutic Interventions
Isha Sharma, Karan Singh Yadav, Madhav Nilakanth Mugale
Pharmacological Research. 2022; : 106292
[Pubmed]  [Google Scholar] [DOI]
3 Gallic acid and myricetin-rich Labisia pumila extract mitigated multiple diabetic eye disorders in rats
Nazmun Nahar, Suhaila Mohamed, Noordin Mohamed Mustapha, Lau Seng Fong, Nur Iliyani Mohd Ishak
Journal of Food Biochemistry. 2021; 45(11)
[Pubmed]  [Google Scholar] [DOI]
4 Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema–Systematic review, meta-analysis and meta-regression
Mohamed Abdel-Maboud, Esraa Menshawy, Eshak I. Bahbah, Oumaima Outani, Amr Menshawy, Demetrios G. Vavvas
PLOS ONE. 2021; 16(1): e0245010
[Pubmed]  [Google Scholar] [DOI]
5 Cellular targets in diabetic retinopathy therapy
María Lucía Rodríguez, Iván Millán, Ángel Luis Ortega
World Journal of Diabetes. 2021; 12(9): 1442
[Pubmed]  [Google Scholar] [DOI]

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy

Giuliana Ribeiro de Carvalho, Vagner Loduca Lima, Glaucia Luciano da Veiga, Fernando Adami, Beatriz da Costa Aguiar Alves, Edimar Cristiano Pereira, David Feder, Fernando Luiz Affonso Fonseca
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 3149
[Pubmed]  [Google Scholar] [DOI]
7 Diabetic Retinopathy and Ocular Melanoma: How Far We Are?
Eliana B. Souto, Joana R. Campos, Raquel Da Ana, Joana F. Fangueiro, Carlos Martins-Gomes, Alessandra Durazzo, Massimo Lucarini, Elena Sánchez López, Marta Espina, Maria Luisa García, Amélia M. Silva, Fernando Mendonça, Antonello Santini, Selma B. Souto
Applied Sciences. 2020; 10(8): 2777
[Pubmed]  [Google Scholar] [DOI]
8 Quercetin attenuates high glucose-induced injury in human retinal pigment epithelial cell line ARPE-19 by up-regulation of miR-29b
Xuejiao Wang, Hui Li, Hao Wang, Jingyun Shi
The Journal of Biochemistry. 2020; 167(5): 495
[Pubmed]  [Google Scholar] [DOI]
9 The protective effects of lycopus lucidus turcz in diabetic retinopathy and its possible mechanisms
Jinlu Liu, Sai Bhuvanagiri, Xiaohan Qu
Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 2900
[Pubmed]  [Google Scholar] [DOI]
10 Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation
Choon-Soo Lee, Yun Gi Kim, Hyun-Jai Cho, Jonghanne Park, Heewon Jeong, Sang-Eun Lee, Seung-Pyo Lee, Hyun-Jae Kang, Hyo-Soo Kim
Scientific Reports. 2016; 6(1)
[Pubmed]  [Google Scholar] [DOI]
11 Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation
Zengyang Yu,Bin Lu,Yuchen Sheng,Lingyu Zhou,Lili Ji,Zhengtao Wang
Biochimica et Biophysica Acta (BBA) - General Subjects. 2015; 1850(4): 824
[Pubmed]  [Google Scholar] [DOI]
12 Identifying and interpreting novel targets that address more than one diabetic complication: a strategy for optimal end organ protection in diabetes
Shinji Hagiwara,Jay C. Jha,Mark E. Cooper
Diabetology International. 2014; 5(1): 1
[Pubmed]  [Google Scholar] [DOI]
13 Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism
Chen-Yuan Gong,Zeng-Yang Yu,Bin Lu,Li Yang,Yu-Chen Sheng,Yuan-Min Fan,Li-Li Ji,Zheng-Tao Wang
Vascular Pharmacology. 2014;
[Pubmed]  [Google Scholar] [DOI]
14 Identifying and interpreting novel targets that address more than one diabetic complication: A strategy for optimal end organ protection in diabetes
Hagiwara, S., Jha, J.C., Cooper, M.E.
Diabetology International. 2014; 5(1): 1-20
[Pubmed]  [Google Scholar]
15 Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats
Niu, C.-S., Chen, L.-J., Niu, H.-S.
BMC Complementary and Alternative Medicine. 2014; 14: 20
[Pubmed]  [Google Scholar]
16 In vitro and ex vivo retina angiogenesis assays
Sara Rezzola,Mirella Belleri,Giuseppina Gariano,Domenico Ribatti,Ciro Costagliola,Francesco Semeraro,Marco Presta
Angiogenesis. 2014; 17(3): 429
[Pubmed]  [Google Scholar] [DOI]
17 Neuropeptides and diabetic retinopathy
Robert Gábriel
British Journal of Clinical Pharmacology. 2013; 75(5): 1189
[Pubmed]  [Google Scholar] [DOI]
18 Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Snježana Kaštelan,Martina Tomic,Antonela Gverovic Antunica,Jasminka Salopek Rabatic,Spomenka Ljubic
Mediators of Inflammation. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
19 Diabetes, obesity and vascular disease - An update
Papanas, N. and Katsiki, N. and Putz, Z. and Mikhailidis, D.P.
Current Pharmaceutical Design. 2013; 19(27): 4900-4903
[Pubmed]  [Google Scholar]
20 Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox
Costa, P.Z. and Soares, R.
Life Sciences. 2013; 92(22): 1037-1045
[Pubmed]  [Google Scholar]
21 Neuropeptides and diabetic retinopathy
Gábriel, R.
British Journal of Clinical Pharmacology. 2013; 75(5): 1189-1201
[Pubmed]  [Google Scholar]
22 Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application
Pollinger, K. and Hennig, R. and Ohlmann, A. and Fuchshofer, R. and Wenzel, R. and Breunig, M. and Tessmar, J. and Tamm, E.R. and Goepferich, A.
Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(15): 6115-6120
[Pubmed]  [Google Scholar]
23 Inflammation and pharmacological treatment in diabetic retinopathy
Kaštelan, S., Tomić, M., Gverović Antunica, A., Salopek Rabatić, J., Ljubić, S.
Mediators of Inflammation. 2013; 2013
[Pubmed]  [Google Scholar]
24 Nowe aspekty farmakoterapii retinopatiicukrzycowej u chorych na cukrzyce typu 2 | [New aspects of pharmacological treatment of diabetic retinopathyin type 2 diabetic patients]
Milczarczyk, A., Franek, E.
Kardiologia Polska. 2013; 71(2): 21-26
[Pubmed]  [Google Scholar]
25 Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: A meta-analysis
Zhang, X.-L., Chen, J., Zhang, R.-J., Zhou, Q., Qin, X.-Y.
International Journal of Ophthalmology. 2013; 6(4): 546-552
[Pubmed]  [Google Scholar]
26 Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application
Klaus Pollinger, Robert Hennig, Andreas Ohlmann, Rudolf Fuchshofer, Rebecca Wenzel, Miriam Breunig, Joerg Tessmar, Ernst R. Tamm, Achim Goepferich
Proceedings of the National Academy of Sciences. 2013; 110(15): 6115
[Pubmed]  [Google Scholar] [DOI]
27 Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox
Paulo Zoé Costa,Raquel Soares
Life Sciences. 2013; 92(22): 1037
[Pubmed]  [Google Scholar] [DOI]


Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow